Latest Observability News

AXP Energy has commenced production from the Greenhorn Formation, marking a first for its Florence leases, while reporting a 15% rise in oil output and a 42% jump in quarterly revenue.

Invion Limited has secured a $20,000 grant to support its anogenital cancer trial and progressed its skin cancer study with promising early results, while raising approximately $1 million through a Loyalty Option Entitlement Offer.

Bayan Mining and Minerals Limited reports promising Carlin-type gold mineralisation at its Nevada projects alongside strategic expansions and a $750,000 capital raise to fuel ongoing exploration.

Ramelius Resources has completed its acquisition of Spartan Resources through a scheme of arrangement, leading to Spartan's imminent delisting from the ASX. Shareholders received a mix of Ramelius shares and cash as part of the transaction.

Taruga Minerals has identified a compelling VTEM bedrock conductor near historic polymetallic workings at its Thowagee Project, with ongoing exploration and assay results expected soon.

OzAurum Resources has confirmed and extended high-grade gold mineralisation at its Mulgabbie North project through multiple drilling programs, while appointing a new chairman to guide its next growth phase.

Western Mines Group has announced a landmark Mineral Resource Estimate for its Mulga Tank project, defining Australia’s largest nickel sulphide deposit with over 5.3 million tonnes of contained nickel. The company has secured government grants and raised capital to accelerate drilling and metallurgical testing.

White Cliff Minerals has expanded its Rae Copper Project in Nunavut, Canada, deploying a second drilling rig and uncovering new copper-rich mineralisation zones near the Danvers deposit. Initial assay results and geophysical survey data are expected soon, potentially reshaping the project's resource outlook.

Nyrada reports successful completion of five cohorts in its Phase I trial of Xolatryp with no safety concerns, alongside compelling preclinical neuro- and cardioprotective data. A Phase IIa trial targeting heart attack patients is slated for early 2026.

Next Science reports a 10% decline in quarterly product sales but advances a $50 million asset sale to Demetra Holdings, signaling a pivotal shift in its business strategy.

Advance Metals reports robust exploration results with standout gold grades at Myrtleford and significant silver-gold intersections at Yoquivo, while advancing acquisitions that broaden its Mexican portfolio.

PVW Resources Limited has appointed David Wheeler as Non-Executive Chairman while director Colin McCavana has resigned, marking a notable shift in the company’s leadership.